GENMAB A/S
Last · CopenhagenDKK 2464.00-6.00 (-0.24%)live · yahoo · 5h ago
Market capDKK 151.5B61.5M sh
P/E · TTM30.9fwd 22.3 · eps 79.71
Beta0.65vs S&P 500
Div yield0.00%annual · TTM
52w range
DKK 1512.00DKK 2603.00
Volume6.3Ksession
| Revenue | $2.1B |
|---|---|
| Operating income | $555.0M |
| Net income | $356.0M |
| Free cash flow | $47.0M |
| Operating margin | 27.1% |
| Net margin | 17.4% |
| Return on equity | 6.0% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-09-02
- Rd Intensity High
Red flags
- Rd Intensity High — R&D/Revenue 43.8%
Upcoming earnings
4:00 PM UTC+1
Period
Sep 2026
Est. EPS
$22.61
Est. revenue
8.0B
Press & signals
- GlobeNewswire
Genmab to Participate in Upcoming Investor Conferences
- GlobeNewswire
Capital Increase in Genmab as a Result of Employee Warrant Exercise
- GlobeNewswire
Genmab Announces Financial Results for the First Half of 2026
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans